New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

A multi-institutional team of Chinese microbiologists and pharmacologists has developed a novel way to fight cancerous tumors. Called ONCOTECH, it combines oncolytic virotherapy and adoptive T cell therapy for treatment of patients with cancerous tumors. The study is published in the journal Nature Biotechnology.

Leave A Comment

Your email address will not be published. Required fields are marked *